Ropinirole CR tablets 8 mg for Parkinson disease

What are Ropinirole 8 mg CR tablets for Parkinson's disease?

Ropinirole hydrochloride, a medication belonging to the class of dopamine agonists, exerts its therapeutic effects by selectively stimulating dopamine D2 receptors in the brain. This activation of D2 receptors helps to compensate for the depleted levels of dopamine in patients with Parkinson's disease, effectively alleviating the symptoms associated with the condition.

When individuals with Parkinson's disease experience stiffness, muscle spasms, poor muscle control, and tremors, it is primarily due to the gradual loss of dopamine-producing neurons in their brain. Ropinirole, by binding to D2 receptors, mimics the action of dopamine and enhances the transmission of nerve signals, leading to improved motor control and a reduction in the severity of these symptoms.

One of the significant advantages of Ropinirole tablets is their excellent tolerability and safety profile. Being an indole derivative, Ropinirole is not associated with the same risk of long-term complications seen with medications belonging to the ergoline class. This characteristic makes Ropinirole a preferred choice for the long-term management of Parkinson's disease, minimizing potential side effects and providing a more favorable outcome for patients.

Moreover, clinical studies have shown that Ropinirole tablets not only alleviate the physical symptoms of Parkinson's disease but also contribute to enhancing the overall quality of life for affected individuals. By effectively managing the motor symptoms, patients often experience increased independence and better mobility, leading to a more active and fulfilling lifestyle.

An additional advantage of Ropinirole is its ability to complement the effects of levodopa, another commonly used medication for Parkinson's disease. Doctors may prescribe Ropinirole alongside levodopa, which allows for a gradual reduction in the dosage of levodopa over time. This is beneficial because as the disease progresses, long-term use of levodopa can lead to certain adverse effects and diminished efficacy. By introducing Ropinirole, the reliance on levodopa can be reduced, maintaining its effectiveness while minimizing potential complications.

Active principles: ropinirole hydrochloride

Amount: 56 tablets

Maker: Towa Pharmaceutical Co., Ltd., Osaka, Japan

Indications:

• treatment for Parkinson's disease and the following symptoms:
• tremor,
• muscle rigidity,
• slow movement
• an abnormal position.

How to take

Adults should start with 2 mg of active principle once a day. After one week, the dosage can be increased up to 4 mg a day. Your doctor can increase the daily dosage by 2 mg each week if necessary. However, the daily dosage should not exceed 16mg of ropinirole. 

This medication can be taken with or without food. It is recommended to take it at the same time every day. Do not crush or chew the tablets. 

Contraindications: do not use for pregnant or breastfeeding women. 

Important information

As this medicine may cause sleepiness or drowsiness, patient should avoid driving a car, operating a dangerous machinery or working at heights. 

Impulsive behavior can occur (pathologically increased sexual desire and appetite; repeatedly excessive or unplanned shopping; etc. ). Patient and their family should receive the full information from their doctor in charge. 

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.